Umbrella Master Protocol: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYNOTE-U01)

Condition:   Carcinoma, Non-Small-Cell Lung Interventions:   Diagnostic Test: Tumor Imaging;   Procedure: Tumor Tissue Collection;   Procedure: Blood Sample Collection Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials